John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 18,887 shares at $35.56 ($672K) on 2023-08-03, disclosed to the SEC on 2023-08-04.
Open-market sale of $672k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.56 | 8,887 | $316K | 47.0% |
| 2 | $35.56 | 8,887 | $316K | 47.0% |
| 3 | $35.92 | 1,113 | $40K | 5.9% |
| Total | $35.58 avg | 18,887 | $672K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |